International Agency for Research on Cancer
iarc.who.intLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
30
Active
12
Phase 3
2
Total enrollment
494,882
Pipeline matrix
Showing 5 of 5 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Triple therapy | — | — | — | — | — | 1 | |
| quadrivalent HPV vaccine | — | — | — | — | — | 1 | |
| HPV vaccine | — | — | — | — | — | 1 | |
| HAV vaccine | — | — | — | — | — | 1 | |
| The study being observational in nature, there is no intervention. The investigators will only collect cervical samples from married women within a specified age range at different intervals. | — | — | — | — | — | 1 |
Next readouts
- 2026-10-30
- 2027-06-30
- 2028-12-01
- 2033-12
Top conditions
- Breast Cancer6
- Cervical Cancer6
- Oral Cancer3
- HPV Infection2
- Colorectal Cancer2
- Lung Cancer1
- Peripheral Vascular Diseases1
- Ankle Brachial Index1
Frequently asked questions about International Agency for Research on Cancer
- How many clinical trials does International Agency for Research on Cancer have on ClinicalTrials.gov?
- International Agency for Research on Cancer is listed as the lead sponsor on 30 clinical trials in ClinicalTrials.gov, 12 of which are currently active (recruiting, enrolling, or ongoing).
- How many of International Agency for Research on Cancer's trials are in Phase 3?
- 2 of International Agency for Research on Cancer's trials are in Phase 3, spread across 5 active drug programs.
- What therapeutic areas does International Agency for Research on Cancer focus on?
- International Agency for Research on Cancer's most-studied conditions on ClinicalTrials.gov are Breast Cancer, Cervical Cancer, Oral Cancer, HPV Infection, Colorectal Cancer.
- When are International Agency for Research on Cancer's next clinical trial readouts?
- International Agency for Research on Cancer has 4 upcoming primary-completion readouts tracked here; the soonest is “Impact of HPV Vaccination on Prevention of Cervical HPV Infection in Sikkim, India”, expected around 2026-10-30.